Hong Kong’s Jacobson Pharma Raises $64 Million For M&A

Currently, Jacobson’s business involves traditional Chinese medicines for the Hong Kong market. One year ago, Jacobson completed an $85 million IPO on the Hong Kong exchange, 45% of which was earmarked for strategic acquisitions.
( read original story …)